The core program in immunology was originally designed to function as an intellectual and technical resource for investigators wishing to study immunologic aspects of AIDS-related issues. This required the recruitment of scientists to this endeavor, and the development of central wet laboratory and flow cytometry facilities capable both of handling virus-infected material and of providing the unique resources and reagents necessary for AIDS-related research. These goals have largely been accomplished as a result of constructing a centralized CFAR immunology laboratory equipped for cellular and molecular studies adjacent to the CFAR BL-3 laboratory, equipping a flow cytometry laboratory with a closed flow system capable of studying viable HIV-or SIV-infected cells, and identifying group of core investigators committed to establishing an AIDS immunology program. The centralized CFAR laboratory, now populated with experienced investigators and technicians, has been at the forefront of the development of methods and reagents for the analysis of cellular immunity to HIV and SIV. The lab is equipped with: culture hoods and incubators necessary for culturing virus-infected cells; HPLC apparatus for purification of proteins, peptides and oligonucleotides; PCR equipment for identifying or isolating DNA or RNA; high-speed centrifuges for isolating viral particles or genetic material; power supplies, gel boxes and darkroom for molecular studies; and beta and gamma-counters for lymphoproliferative and cytotoxic assays. This equipment, and the reagents generated by core investigators such as purified viral proteins, recombinant vaccinia and retrovirus shuttle vectors, and monoclonal antibodies, are available to center scientists for individual use or collaborative studies. The AIDS flow cytometry facility contains a cell sorter and two cell analyzers, and is available on a priority basis for CFAR investigators. Since this is only facility at our institution that can handle viable HIV-infected cells, it is widely used for AIDS-related studies by investigators from many disciplines. The planned focus of the immunology core in future years is to provide: (a) technical assistance, training and reagents necessary for the analysis of immune responses to HIV and SIV and (b) technical assistance, reagents and the equipment necessary for sophisticated flow cytometric analysis and isolation of virus-infected and uninfected cells. Such efforts are expected, as in the past, to continue to promote interdisciplinary collaborations, particularly with participants in the Clinical Research, Clinical Retrovirology and Molecular Retrovirology CFAR cores.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027757-09
Application #
6234911
Study Section
Project Start
1997-03-01
Project End
1998-02-28
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Fairbanks, Jade; Beima-Sofie, Kristin; Akinyi, Pamela et al. (2018) You Will Know That Despite Being HIV Positive You Are Not Alone: Qualitative Study to Inform Content of a Text Messaging Intervention to Improve Prevention of Mother-to-Child HIV Transmission. JMIR Mhealth Uhealth 6:e10671
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Sauceda, John A; Wiebe, John S; Chan, Kiana et al. (2018) Acculturation, family cohesion, and mental health among Latinos living with HIV on the U.S.-Mexico border. Cultur Divers Ethnic Minor Psychol 24:453-458
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Nevin, Paul E; Frey, Sarah; Lipira, Lauren et al. (2018) ""You are always hiding. It's the worst way to live."" Exploring Stigma in African Immigrants Living With HIV in a Large Northwest U.S. Metropolitan Area. J Assoc Nurses AIDS Care 29:417-425
Jenness, Samuel M; Goodreau, Steven M; Morris, Martina (2018) EpiModel: An R Package for Mathematical Modeling of Infectious Disease over Networks. J Stat Softw 84:
Kraft, John C; McConnachie, Lisa A; Koehn, Josefin et al. (2018) Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation. J Control Release 275:229-241
Suter, Megan K; Karr, Catherine J; John-Stewart, Grace C et al. (2018) Implications of Combined Exposure to Household Air Pollution and HIV on Neurocognition in Children. Int J Environ Res Public Health 15:
Balkus, Jennifer E; Manhart, Lisa E; Jensen, Jørgen S et al. (2018) Mycoplasma genitalium Infection in Kenyan and US Women. Sex Transm Dis 45:514-521

Showing the most recent 10 out of 1275 publications